Search

everythinglearnresearchcommunity

for

Search:↓

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Phospholipases help maintain and restore skin and hair health, potentially leading to new treatments for related conditions.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

The skin condition PUPP usually gets better on its own after giving birth and is unlikely to happen again in future pregnancies.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Alopecia areata is linked to autoimmune antibodies.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

The patient had paraneoplastic pemphigus without mucosal involvement.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

PUVA treatment may have triggered lupus in a woman with psoriasis.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.